Results 21 to 30 of about 144,316 (318)
Neuronal damage after moderate hypoxia and erythropoietin
Neurobiology of Disease, 2005 Both mild hypoxia and exogenous erythropoietin may protect the brain against subsequent severe hypoxia, and the conditioning effect of transient hypoxia is partly mediated by hypoxia-induced endogenous erythropoietin.
Astrid Weber +8 more
doaj +1 more source
Evaluation of the stability of human erythropoietin in samples for radioimmunoassay [PDF]
, 1988 Radioimmunoassays for erythropoietin are limited so far to a few specialized laboratories and this requires transport and storage of samples. We therefore tested the stability of immunoreactive erythropoietin in serum and plasma samples obtained from a ...
Bauer, Christian +5 more
core +1 more source
Journal of Medical Case Reports, 2023 Background Absolute polycythemia can be primary or secondary. Erythropoietin-producing diseases (for example, hypoxia) are the major cause of secondary polycythemia. There are reports of polycythemia secondary to hydronephrosis. However, to our knowledge,
Yuriko Hajika +3 more
doaj +1 more source
Sensitivity and specificity of detection methods for erythropoietin doping in cyclists [PDF]
, 2019 Recombinant human erythropoietin (rHuEPO) is used as doping a substance. Anti-doping efforts include urine and blood testing and monitoring the athlete biological passport (ABP).
Burggraaf, Jacobus +10 more
core +1 more source
Cold Spring Harbor Perspectives in Medicine, 2013 During the past century, few proteins have matched erythropoietin (Epo) in capturing the imagination of physiologists, molecular biologists, and, more recently, physicians and patients. Its appeal rests on its commanding role as the premier erythroid cytokine, the elegant mechanism underlying the regulation of its gene, and its remarkable impact as a ...
openaire +2 more sources
Erythropoietin reduces storage lesions and decreases apoptosis indices in blood bank red blood cells
Revista Brasileira de Hematologia e Hemoterapia, 2016 Background: Recent evidence shows a selective destruction of the youngest circulating red blood cells (neocytolysis) trigged by a drop in erythropoietin levels.
Oscar Andrés Penuela +2 more
doaj +1 more source
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy. [PDF]
, 2002 In part A of this study, patients were randomised to cohorts receiving darbepoetin alfa at doses of 0.5 to 8.0 m.c.g x kg(-1) x wk(-1) or to a control group receiving epoetin alfa at an initial dose of 150 U x kg(-1) three times weekly.
Armstrong, S +10 more
core +2 more sources
Haematologica, 2013 Erythropoiesis stimulating agents are widely used for the treatment of anemia. Recently, we reported erythroid expansion with impaired B lymphopoiesis and loss of trabecular bone in C57BL/6 mice following ten days of treatment with low-dose short acting ...
Sita R. Dewamitta +3 more
doaj +1 more source
Predictors of hyporesponsiveness to erythropoietin in prevalent hemodialysis patients and its association with mortality [PDF]
Revista Portuguesa de Nefrologia e Hipertensão, 2022 Introduction: Erythropoietin-stimulating agents hyporesponsiveness is common among hemodialysis patients. The aim was to analyze factors predictive of Erythropoietin-stimulating agent resistance and its association with mortality.
Marisa Roldão +5 more
doaj +1 more source
Increased plasma viscosity as a reason for inappropriate erythropoietin formation [PDF]
, 1993 The aim of this study was to examine whether altered plasma viscosity could contribute to the inappropriately low production rate of erythropoietin (EPO) observed in patients suffering from hypergammaglobulinemias associated with multiple myeloma or ...
Eckardt, Kai-Uwe +7 more
core +2 more sources